Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi - 14 Apr 2026

Wang X, Liu L L, Li B, Jia Y J, Li C W, Qin T J, Xu Z F, Qu S Q, Pan L J, Gao Q Y, Jiao M, Xiao Z J

Abstract excerpt

Objective: To explore the clinical characteristics and prognostic significance of myelodysplastic neoplasms (MDS) with biallelic TET2 inactivation (bi-TET2) . Methods: Clinical data from 1 730 newly diagnosed de novo MDS patients treated at Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College between August 2016 and June 2025, with next-generation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dioxygenases
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to SF3B1 gene

Share to Loss of Heterozygosity

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Prognosis

Share to Proto-Oncogene Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 42161655
DOI: 10.3760/cma.j.cn121090-20260115-00025
PMCID: PMC13195553

Genes

TET2
CBL
CUX1
KRAS
SF3B1
SRSF2
ZRSR2
ASXL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Molecular and clinical characteristics and prognosis of myelodysplastic neoplasms with biallelic TET2 inactivation].PMID 42161655Read ↗

Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study.Semantic proximity Read ↗

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read ↗

Molecular taxonomy of myelodysplastic syndromes and its clinical implications.Semantic proximity Read ↗

Landscape of TET2 Mutations: From Hematological Malignancies to Solid TumorsSemantic proximity Read ↗

TET2 mutations in myelodysplasia and myeloid malignancies.Semantic proximity Read ↗

Acquired mutations in TET2 are common in myelodysplastic syndromes.Semantic proximity Read ↗

Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome.Semantic proximity Read ↗

TET2 mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemiaSemantic proximity Read ↗

Ten-eleven-translocation 2 (TET2) is downregulated in myelodysplastic syndromes.Semantic proximity Read ↗

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.Semantic proximity Read ↗

Pedigree Investigation, Clinical Characteristics and Prognosis Analysis of Hematological Disease Patients with Germline TET2 MutationSemantic proximity Read ↗

TET2: A cornerstone in normal and malignant hematopoiesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.